These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 38270698)
1. Prognostic Value of CXCR6 and the Correlation with Immune Infiltration in the Microenvironment of Skin Cutaneous Melanoma. Ding G; Zhang T; Yu H; Ma J; Wang Y; Chen Y; Cheng X Biochem Genet; 2024 Oct; 62(5):4027-4045. PubMed ID: 38270698 [TBL] [Abstract][Full Text] [Related]
2. Prognostic and immune infiltration implications of SIGLEC9 in SKCM. Yang P; Jiang Y; Chen R; Yang J; Liu M; Huang X; Xu G; Hao R Diagn Pathol; 2024 Aug; 19(1):112. PubMed ID: 39153970 [TBL] [Abstract][Full Text] [Related]
3. PMEL as a Prognostic Biomarker and Negatively Associated With Immune Infiltration in Skin Cutaneous Melanoma (SKCM). Zhang S; Chen K; Liu H; Jing C; Zhang X; Qu C; Yu S J Immunother; 2021 Jul-Aug 01; 44(6):214-223. PubMed ID: 34028390 [TBL] [Abstract][Full Text] [Related]
4. RARRES1 identified by comprehensive bioinformatic analysis and experimental validation as a promising biomarker in Skin Cutaneous Melanoma. Liu M; Bai R; Zhang G; Liu X; Wang Z; He K; Gan X; Zhou X; Yin P; Zheng Y; Wang G Sci Rep; 2024 Jun; 14(1):14113. PubMed ID: 38898266 [TBL] [Abstract][Full Text] [Related]
5. Analysis on tumor immune microenvironment and construction of a prognosis model for immune-related skin cutaneous melanoma. Wu M; Wang Z; Zhang J Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 May; 48(5):671-681. PubMed ID: 37539569 [TBL] [Abstract][Full Text] [Related]
6. Based on scRNA-seq and bulk RNA-seq to establish tumor immune microenvironment-associated signature of skin melanoma and predict immunotherapy response. Li S; Zhao J; Wang G; Yao Q; Leng Z; Liu Q; Jiang J; Wang W Arch Dermatol Res; 2024 May; 316(6):262. PubMed ID: 38795156 [TBL] [Abstract][Full Text] [Related]
7. Aspartate beta-hydroxylase domain containing 1 as a prognostic marker associated with immune infiltration in skin cutaneous melanoma. Sun S; Deng M; Wen J; Chen X; Xu J; Liu Y; Wan H; Wang J; Yan L; He Y; Xu Y BMC Cancer; 2023 Mar; 23(1):292. PubMed ID: 37004045 [TBL] [Abstract][Full Text] [Related]
8. Prognostic and immune-related value of STK17B in skin cutaneous melanoma. Shi X; Zhou Q; Huang B; Xia S; Jiang Y; Fang S; Lin J PLoS One; 2022; 17(2):e0263311. PubMed ID: 35171924 [TBL] [Abstract][Full Text] [Related]
9. The prognostic landscape of adaptive immune resistance signatures and infiltrating immune cells in the tumor microenvironment of uveal melanoma. Wang Y; Xu Y; Dai X; Lin X; Shan Y; Ye J Exp Eye Res; 2020 Jul; 196():108069. PubMed ID: 32439398 [TBL] [Abstract][Full Text] [Related]
10. Comprehensive Analysis of the Immune Implication of TEX41 in Skin Cutaneous Melanoma. Chen ZY; Huang JQ; Zhu Y; Chen YS; Yu XF Dis Markers; 2021; 2021():2409820. PubMed ID: 34795805 [TBL] [Abstract][Full Text] [Related]
11. Development of an IFNγ response-related signature for predicting the survival of cutaneous melanoma. Hu B; Wei Q; Li X; Ju M; Wang L; Zhou C; Chen L; Li Z; Wei M; He M; Zhao L Cancer Med; 2020 Nov; 9(21):8186-8201. PubMed ID: 32902917 [TBL] [Abstract][Full Text] [Related]
12. Development of a biomarker signature associated with anoikis to predict prognosis and immunotherapy response in melanoma. Wu Z; Zhang R; Bao J; Yin M; Wang X Arch Dermatol Res; 2024 May; 316(6):219. PubMed ID: 38787413 [TBL] [Abstract][Full Text] [Related]
13. Experimentally validated oxidative stress -associated prognostic signatures describe the immune landscape and predict the drug response and prognosis of SKCM. Rong D; Su Y; Jia D; Zeng Z; Yang Y; Wei D; Lu H; Cao Y Front Immunol; 2024; 15():1387316. PubMed ID: 38660305 [TBL] [Abstract][Full Text] [Related]
14. Data mining of immune-related prognostic genes in metastatic melanoma microenvironment. Han W; Huang B; Zhao XY; Shen GL Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33169786 [TBL] [Abstract][Full Text] [Related]
15. Systematic expression analysis of EAF family reveals the importance of EAF2 in melanoma. Han W; Shen GL Int Immunopharmacol; 2020 Nov; 88():106958. PubMed ID: 33182068 [TBL] [Abstract][Full Text] [Related]
16. The role of SRGN in the survival and immune infiltrates of skin cutaneous melanoma (SKCM) and SKCM-metastasis patients. Wang X; Xiong H; Liang D; Chen Z; Li X; Zhang K BMC Cancer; 2020 May; 20(1):378. PubMed ID: 32370744 [TBL] [Abstract][Full Text] [Related]
17. Identification of novel disulfidptosis-related lncRNA signatures to predict the prognosis and immune microenvironment of skin cutaneous melanoma patients. Cheng S; Wang X; Yang S; Liang J; Song C; Zhu Q; Chen W; Ren Z; Zhu F Skin Res Technol; 2024 Jul; 30(7):e13814. PubMed ID: 38924611 [TBL] [Abstract][Full Text] [Related]
18. Low expression of endoplasmic reticulum stress-related gene SERP1 is associated with poor prognosis and immune infiltration in skin cutaneous melanoma. Fan Y; Liang X; Yu D Aging (Albany NY); 2021 Oct; 13(19):23036-23071. PubMed ID: 34613934 [TBL] [Abstract][Full Text] [Related]
19. Analysis of immune subtypes based on immunogenomic profiling identifies prognostic signature for cutaneous melanoma. Hu B; Wei Q; Zhou C; Ju M; Wang L; Chen L; Li Z; Wei M; He M; Zhao L Int Immunopharmacol; 2020 Dec; 89(Pt A):107162. PubMed ID: 33168410 [TBL] [Abstract][Full Text] [Related]
20. Development and validation of an immune gene set-based prognostic signature in cutaneous melanoma. Tian Q; Gao H; Zhao W; Zhou Y; Yang J Future Oncol; 2021 Nov; 17(31):4115-4129. PubMed ID: 34291650 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]